Massive Suprachoroidal Hemorrhage Following Needling Bleb Revision: Two Case Reports Authors: Euido Song, Do Young Park Published: 2026 Dear Editor Suprachoroidal hemorrhage (SCH) is a rare but vision-threatening complication associated with intraocular procedures, including glaucoma filtering, cataract, and vitreo-retinal surgery [1]. Although established risk factors such as elevated intraocular pressure (IOP), aphakia or pseudophakia, prior vitrectomy, and systemic vascular comorbidities are well recognized [1–3], massive SCH after needling bleb revision may be underappreciated. We report two cases of massive SCH following needling bleb revision in vitrectomized eyes, highlighting different clinical courses and management. Written informed consent for the publication of the research details and clinical images was obtained from the patients. An 82-year-old aphakic male patient, who had undergone combined pars plana vitrectomy and trabeculectomy in the right eye, presented with bleb flattening and IOP of 24 mmHg 4 months postoperatively. His best-corrected visual acuity (BCVA) in the right eye was 0.4 and axial length was 24.19 mm. Needling bleb revision was performed in the outpatient clinic under topical anesthesia using a 26-gauge needle introduced transconjunctivally to release subconjunctival and episcleral adhesions around the scleral flap. No anterior chamber puncture was performed and no antimetabolite or viscoelastic was used; the anterior chamber remained well formed without hyphema. The following day, he returned with ocular pain, hand-motion vision, an IOP of 2 mmHg, and a 3-mm hyphema; B-scan ultrasonography confirmed massive SCH (Fig. 1A, 1B). Posterior sclerotomy was initially performed in the superonasal quadrant under local anesthesia 3 days after SCH onset, resulting in only partial drainage due to patient discomfort. A second sclerotomy under general anesthesia with two-quadrant drainage was performed 3 days later. One month later, retinal detachment from a tear remote from the sclerotomy sites required vitrectomy with silicone oil tamponade (Fig. 1C). Six months later, BCVA was 0.3 and IOP was 18 mmHg with topical latanoprost (Fig. 1D). A 50-year-old male patient with a history of bilateral cataract surgery and vitrectomy in the left eye for retinal detachment 3 years prior underwent bilateral trabeculectomy for primary open-angle glaucoma. Ten months after trabeculectomy, BCVA in the left eye was 0.05 and IOP was 29 mmHg. The axial length was 26.65 mm. Needling bleb revision was then performed as in case 1, with subconjunctival 5-fluorouracil (5 mg/0.1 mL). That evening, he experienced prolonged coughing, followed the next morning by sudden visual loss. He presented 4 days later with BCVA of light perception and IOP of 4 mmHg. B-scan ultrasonography confirmed massive SCH (Fig. 1E). Despite recommendations for surgical drainage, he chose conservative management with oral prednisolone and topical homatropine. SCH resolved spontaneously within 3 months; final BCVA was finger counting at 40 cm, and IOP was 16 mmHg with dorzolamide/ timolol, brimonidine, and latanoprost (Fig. 1F). Although needling is often regarded as a safe outpatient procedure, its “blind” nature means aqueous outflow cannot always be precisely controlled, predisposing susceptible eyes to abrupt decompression [4]. Both patients had undergone vitrectomy and cataract surgery, making their eyes more vulnerable to sudden IOP changes due to reduced vitreous support [1,3]. In case 2, an axial length of 26.65 mm, a risk factor associated with choroidal vascular fragility, combined with a coughing-induced Valsalva maneuver likely precipitated SCH in the hypotonous eye. In eyes with these risk factors, escalation of medical therapy or surgical revision under direct visualization allowing more controlled filtration should be considered. If needling is attempted, aggressive adhesion dissection and unnecessary scleral flap manipulation should be avoided. Additionally, patients should be informed about the risk of SCH before the procedure and counseled to avoid Valsalva-inducing activities, such as heavy lifting or repeated coughing. No single algorithm exists for managing massive SCH; treatment must be individualized. Surgical drainage is generally indicated for kissing choroidal apposition, uncontrolled IOP, or rhegmatogenous retinal detachment, typically deferred 7 to 14 days to allow clot liquefaction [1]. In case 1, persistent kissing configuration necessitated two staged sclerotomies, ultimately requiring vitrectomy for retinal detachment. In case 2, despite kissing choroidal apposition, the patient declined surgery; spontaneous resolution under conservative management was consistent with prior reports [5], suggesting that close observation may be an option in selected cases. In conclusion, needling bleb revision carries an underappreciated risk of massive SCH in vitrectomized, aphakic, or pseudophakic eyes. Careful patient selection, gradual release of adhesions during needling, and perioperative Valsalva counseling may reduce the risk of this sight-threatening complication.